Table 2.

The prevalence of atrial cardiopathy in ESUS/LAA/SVO.

	ESUS (n = 105)	LAA (n = 84)	SVO (n = 73)	P-value
PTFV1 >5,000 μV · ms, % (n)	20.00 (21)	8.30 (7)	4.11 (3)	0.003
NT-proBNP >250 pg/mL, % (n)	36.19 (38)	7.14 (6)	4.11 (3)	<0.001
Atrial cardiopathy, % (n)	42.86 (45)	17.86 (15)	8.22 (6)	<0.001

ESUS, embolic strokes of undetermined source; LAA, large-artery atherosclerosis; SVO, small-vessel occlusion; PTFV1, P wave terminal force in lead V1; NT-proBNP, N-Terminal pro-brain natriuretic peptide.